Infectious bacterial keratitis management in a Swedish region: Risk factors, treatment and time‐to‐resolution
Acta Ophthalmologica · 2026
DOI: 10.1111/aos.70141 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Ophthalmologica, 2026. Verfasst von Jenny Roth und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Optometry, Linnaeus University, Kalmar, Sweden. Hauptthemen laut MEDLINE: Eye Infections, Bacterial, Anti-Bacterial Agents, Keratitis, Bacteria. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Forskningsrådet i Sydöstra Sverige, Optikbranchen (Swedish Optical Industry).
Abstract (Originalsprache)
Purpose
To report treatment patterns, time‐to‐resolution (TTR) and aetiologies of bacterial keratitis (BK) infections treated in a specialized hospital‐based cornea clinic in Sweden.
Methods
Retrospective study based on electronic health records screened during the period 2010–2019. The study included only culture‐confirmed cases of BK. TTR was defined as the number of days from the sample collection for microbiological culture to the date that the cornea healed. Factors affecting TTR were investigated with Cox regression models.
Results
Contact lens wear and severely ill/blind eye were the most common aetiologies among the 188 patients. Empirical treatment consisted of fluoroquinolones in combination with aminoglycosides in 50% of the patients. Median TTR was 22 days (95% CI: 12, 34) for contact lens–related BK and 90 days (95% CI: 55, 146) in complicated cases with miscellaneous or unknown aetiology. Hazard ratio (HR) for infections in females (HR = 1.93; 95% CI: 1.34, 2.79), contact lens wearers (HR = 2.72; 95% CI: 1.79, 4.14) and infections caused by Gram‐positive pathogens (HR = 2.50; 95% CI: 1.50, 4.19) indicated that infections in these categories healed at a faster rate than their reference categories. Patients switching to treatment with chloramphenicol after it was absent in the empirical treatment had a slower rate of healing than those who received chloramphenicol as part of the empirical treatment (HR = 0.58; 95% CI: 0.38, 0.87).
Conclusions
The current study provides unique TTR estimates for BK. The results revealed that age, sex, aetiology, empirical treatment and Gram staining can affect TTR. In our sample, empirical treatment that includes chloramphenicol could potentially reduce TTR. These findings can be used to individualize disease management and prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine and Optometry, Linnaeus University, Kalmar, Sweden.
- Department and Centre of Physics-Optometry and Vision Science, University of Minho, Braga, Portugal.
- Department of Chemistry and Biomedical Sciences, Linnaeus University, Kalmar, Sweden.
- Clinical Microbiology, Region Kronoberg, Växjö/Karlskrona, Sweden.
- Department of Biomedical and Clinical Sciences, Faculty of Medicine, Linköping University, Linköping, Sweden.
- Department of Ophthalmology, Sørlandet Hospital, Arendal, Norway.
ORCID-Profile: Jenny Roth, Antonio Filipe Macedo, Neil Lagali
Förderung
- Forskningsrådet i Sydöstra Sverige
- Optikbranchen (Swedish Optical Industry)
Zitieren
APA
Roth, J., Macedo, A. F., Somajo, S., Tannerfeldt, L., Toprak, B., & Lagali, N. (2026). Infectious bacterial keratitis management in a Swedish region: Risk factors, treatment and time‐to‐resolution. Acta Ophthalmologica. https://doi.org/10.1111/aos.70141
Vancouver
Roth J, Macedo AF, Somajo S, Tannerfeldt L, Toprak B, Lagali N. Infectious bacterial keratitis management in a Swedish region: Risk factors, treatment and time‐to‐resolution. Acta Ophthalmologica. 2026. doi:10.1111/aos.70141
BibTeX
@article{Roth2026,
author = {Roth, Jenny and Macedo, Antonio Filipe and Somajo, Sofia and Tannerfeldt, Lukas and Toprak, Baris and Lagali, Neil},
title = {Infectious bacterial keratitis management in a Swedish region: Risk factors, treatment and time‐to‐resolution},
journal = {Acta Ophthalmologica},
year = {2026},
doi = {10.1111/aos.70141}
}
EUVIMED